NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased…
COLUMBUS, Ohio, April 7, 2025 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific content and…
BEIJING, April 7, 2025 /PRNewswire/ -- A report from Science and Technology Daily: The 2025 Zhongguancun Forum Annual Conference (2025 ZGC…
SAN MATEO, Calif., April 7, 2025 /PRNewswire/ -- Cala, the bioelectronic medicine leader, who recently raised an oversubscribed growth financing round…
New Wellness Solutions Available Starting April 2025, Empowering Women to Prioritize Their Brain Health LOS ANGELES, April 7, 2025 /PRNewswire/…
The Pilot Program uses a unique "Human + AI" (HAI) model to interact with patients & monitor progress. LONDON, April…
Subcutaneous (SC) amivantamab offers patients greater convenience, reducing administration time from hours to minutes and with a five-fold reduction in…
Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells…
Lenire proudly sponsors the 10th Annual LexCare Hearing Foundation Hearoes Tour.Lenire is a treatment option for 3.2m veterans living with…
ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine…